company background image
1093 logo

CSPC Pharmaceutical Group SHSC:1093 Stock Report

Last Price

HK$4.80

Market Cap

HK$55.7b

7D

3.7%

1Y

-30.1%

Updated

24 Dec, 2024

Data

Company Financials +

CSPC Pharmaceutical Group Limited

SHSC:1093 Stock Report

Market Cap: HK$55.7b

1093 Stock Overview

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally. More details

1093 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 50.1% below our estimate of its fair value

Earnings are forecast to grow 3.07% per year

Risk Analysis

Dividend of 6.59% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

CSPC Pharmaceutical Group Limited Competitors

Sino Biopharmaceutical

SEHK:1177

HK$58.6b

China Resources Pharmaceutical Group

SEHK:3320

HK$34.6b

Hansoh Pharmaceutical Group

SEHK:3692

HK$105.7b

United Laboratories International Holdings

SEHK:3933

HK$21.3b

Price History & Performance

Summary of share price highs, lows and changes for CSPC Pharmaceutical Group
Historical stock prices
Current Share PriceHK$4.80
52 Week HighHK$7.83
52 Week LowHK$4.45
Beta0.64
1 Month Change-5.70%
3 Month Change-8.40%
1 Year Change-30.13%
3 Year Change-41.82%
5 Year Change-50.40%
Change since IPO26.94%

Recent News & Updates

Recent updates

Shareholder Returns

1093HK PharmaceuticalsHK Market
7D3.7%0.3%0.8%
1Y-30.1%-3.8%21.1%

Return vs Industry: 1093 underperformed the Hong Kong Pharmaceuticals industry which returned -3.8% over the past year.

Return vs Market: 1093 underperformed the Hong Kong Market which returned 21.1% over the past year.

Price Volatility

Is 1093's price volatile compared to industry and market?
1093 volatility
1093 Average Weekly Movement7.2%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 1093 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1093's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199220,300Cuilong Zhangwww.cspc.com.hk

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.

CSPC Pharmaceutical Group Limited Fundamentals Summary

How do CSPC Pharmaceutical Group's earnings and revenue compare to its market cap?
1093 fundamental statistics
Market capHK$55.67b
Earnings (TTM)HK$5.49b
Revenue (TTM)HK$32.22b

10.1x

P/E Ratio

1.7x

P/S Ratio

Is 1093 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1093 income statement (TTM)
RevenueCN¥30.27b
Cost of RevenueCN¥8.90b
Gross ProfitCN¥21.37b
Other ExpensesCN¥16.21b
EarningsCN¥5.16b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.44
Gross Margin70.59%
Net Profit Margin17.04%
Debt/Equity Ratio1.1%

How did 1093 perform over the long term?

See historical performance and comparison

Dividends

6.6%

Current Dividend Yield

61%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 02:29
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 50 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wai Chak YuenBOCI Research Ltd.
Sharon ShiBOCI Research Ltd.
Ethan CuiBofA Global Research